Conclusion
The 1-year results of the single-center study support the safety and effectiveness of the J-Valve® in treating the elderly, high-risk patients with severe AR. Low all-cause mortality, major stroke and no moderate and severe PVL were observed. J-Valve has the advantages of self-position and anatomically correct implantation. However, the rate of PPMI was slightly high. More clinical studies and longer-term follow-up are needed to validate these promising findings further.